Geriatric Research and Education Clinical Center and
Division of Nephrology and.
J Am Soc Nephrol. 2018 Aug;29(8):2169-2177. doi: 10.1681/ASN.2017121273. Epub 2018 May 22.
Appropriate patient selection and optimal timing of dialysis initiation among older adults with advanced CKD are uncertain. We determined the association between dialysis versus medical management and survival at different ages and levels of kidney function. We assembled a nationally representative 20% sample of United States veterans with eGFR<30 ml/min per 1.73 m between 2005 and 2010 (=73,349), with follow-up through 2012. We used an extended Cox model to determine associations among the time-varying exposures, age (<65, 65-74, 75-84, and ≥85 years), eGFR (<6, 6-<9, 9-<12, 12-<15, and 15-<29 ml/min per 1.73 m), and provision of dialysis, and survival. Over the mean±SEM follow-up of 3.4±2.2 years, 15% of patients started dialysis and 52% died. The eGFR at which dialysis, compared with medical management, associated with lower mortality varied by age (<0.001). For patients aged <65, 65-74, 75-84, and ≥85 years, dialysis associated with lower mortality for those with eGFR not exceeding 6-<9, <6, 9-<12, and 9-<12 ml/min per 1.73 m, respectively. Dialysis initiation at eGFR<6 ml/min per 1.73 m associated with a higher median life expectancy of 26, 25, and 19 months for patients aged 65, 75, and 85 years, respectively. When dialysis was initiated at eGFR 9-<12 ml/min per 1.73 m, the estimated difference in median life expectancy was <1 year for these patients. Provision of dialysis at higher levels of kidney function may extend survival for some older patients.
在患有晚期 CKD 的老年人中,适当的患者选择和透析启动的最佳时机尚不确定。我们确定了透析与药物治疗之间的关系,并根据不同年龄和肾功能水平来评估生存率。我们收集了美国退伍军人的一个具有代表性的 20%样本,他们在 2005 年至 2010 年期间的 eGFR<30 ml/min per 1.73 m(=73349 人),随访至 2012 年。我们使用扩展的 Cox 模型来确定时间变化的暴露、年龄(<65 岁、65-74 岁、75-84 岁和≥85 岁)、eGFR(<6ml/min per 1.73 m、6-<9ml/min per 1.73 m、9-<12ml/min per 1.73 m、12-<15ml/min per 1.73 m 和 15-<29ml/min per 1.73 m)以及透析的提供与生存率之间的关联。在平均随访 3.4±2.2 年后,有 15%的患者开始透析,52%的患者死亡。与药物治疗相比,开始透析时的 eGFR 与死亡率相关,而 eGFR 与死亡率相关的年龄范围因年龄而异(<0.001)。对于年龄<65 岁、65-74 岁、75-84 岁和≥85 岁的患者,对于 eGFR 不超过 6-<9、<6、9-<12 和 9-<12ml/min per 1.73 m 的患者,透析与较低的死亡率相关。对于 eGFR<6ml/min per 1.73 m 的患者,年龄分别为 65、75 和 85 岁的患者的预期中位预期寿命分别为 26、25 和 19 个月。对于 eGFR 在 9-<12ml/min per 1.73 m 时开始透析的患者,这些患者的预期中位预期寿命差异<1 年。在更高水平的肾功能时提供透析可能会延长某些老年患者的生存时间。